glp 1 oral medications Novo Nordisk's GLP-1 drug didn't work on Alzheimer's as hoped, but don't call it a failure Lesson: Oral Semaglutide: A New

"In combination with diet and exercise, Wegovy is the only obesity medicine proven to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight

Mozaffarian D et al

doi: 10.1002/dmrr.1080

Mousai Wellness Center 18/2,3 Class 1, Soi Sukhumvit 39, Khlong Tan Nuea, Watthana, Bangkok 10110 (Near BTS Phrom Phong | Adjacent to EmQuartier) 02-096-4991 | 061-894-1881 www.mousaiwellness.com LINE: @MousaiWellness WhatsApp: +66 61 894 1881 Early detection

An extension analysis of the original STEP-1 trial (n = 327) aimed to observe weight gain and cardiometabolic effects after withdrawal of both SC semaglutide and lifestyle interventions following 68 weeks of therapy